| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Revenue | $188.6M | +28.2% |
| Cost of Revenue | $177.2M | +22.9% |
| Gross Profit | $11.4M | +296.7% |
| R&D Expense | $3.5M | -56.6% |
| SG&A Expense | $13.2M | +9.4% |
| Operating Income | -$25.5M | +53.8% |
| Pre-tax Income | -$24.8M | +53.9% |
| Income Tax | $1K | +0.0% |
| Net Income | -$24.8M | +53.9% |
| EPS (Basic) | -$0.09 | +57.1% |
| EPS (Diluted) | -$0.09 | +57.1% |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.8M | +41.2% |
| Accounts Receivable | $2.4M | +44.3% |
| Inventory | $3.4M | +23.3% |
| Current Assets | $48.2M | +21.3% |
| Total Assets | $49.5M | +18.3% |
| Current Liabilities | $54.6M | +16.1% |
| Total Liabilities | $54.7M | +14.2% |
| Stockholders' Equity |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.7M | +57.4% |
| Capital Expenditures | $42K | -40.8% |
| Investing Cash Flow | -$42K | +40.8% |
| Financing Cash Flow | $22.3M | +35.5% |
| Free Cash Flow | -$14.8M | +57.4% |
| -$5.2M |
| +14.0% |